Chemoinformaics analysis of Citronellyl isobutyrate
| Molecular Weight | 226.36 | nRot | 7 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 2 |
| Exact Molecular Weight | 226.193 | nRing | 0 |
| Solubility: LogS | -2.641 | nHRing | 0 |
| Solubility: LogP | 3.383 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 42.3206 |
| nHD | 0 | BPOL | 28.6874 |
| QED | 0.348 |
| Synth | 2.45 |
| Natural Product Likeliness | 2.16 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.011 |
| HIA | 0.005 |
| CACO-2 | -4.568 |
| MDCK | 0.0000291 |
| BBB | 0.998 |
| PPB | 0.75549 |
| VDSS | 0.935 |
| FU | 0.355269 |
| CYP1A2-inh | 0.949 |
| CYP1A2-sub | 0.29 |
| CYP2c19-inh | 0.548 |
| CYP2c19-sub | 0.633 |
| CYP2c9-inh | 0.282 |
| CYP2c9-sub | 0.49 |
| CYP2d6-inh | 0.108 |
| CYP2d6-sub | 0.113 |
| CYP3a4-inh | 0.268 |
| CYP3a4-sub | 0.234 |
| CL | 4.88 |
| T12 | 0.738 |
| hERG | 0.014 |
| Ames | 0.002 |
| ROA | 0.015 |
| SkinSen | 0.961 |
| Carcinogencity | 0.891 |
| EI | 0.979 |
| Respiratory | 0.434 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.805497 |